Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT
Oncolytics Biotech Cash Flow Statement
Financials in CAD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.69M | -8.02M | -9.54M | -7.26K | -6.89M | -3.95M | -9.93M | -7.44M | -6.44M | -8.55M | -4.41M | -5.09M | -6.78M | -7.75M | -4.87M | -7.25M | -6.43M |
Depreciation & Amortization | 97K | 98K | 105K | 98.00 | 123K | 107K | 103K | 96K | 97K | 99.01K | 97.82K | 97.61K | 97.56K | 96.97K | 84.52K | 163.83K | 106.73K |
Stock-Based Compensation | 1.21M | 1.2M | 445K | 506K | 576K | 759K | 750K | 242K | 317K | 748.98K | 500K | 490.11K | 639K | 1.13M | 1.01M | 1.03M | 658.08K |
Other Working Capital | -833K | -960K | 4.32M | 641.00 | 54K | 911K | 3.75M | -2.05M | -1.35M | 1.86M | 956.77K | -1.35M | -656.8K | -132.17K | 1.23M | -1.4M | -596.48K |
Other Non-Cash Items | -262K | -163K | -155K | -504.83K | -332K | -4.21M | 74K | 75K | -251K | -71.66K | -1.25M | -802.81K | 446.66K | 25.88K | 27.59K | 24.45K | 13.81K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -358K | -707K | 444K | n/a | n/a | n/a | n/a | n/a | 296.23K | -1.21M | 633.6K | 684.15K |
Change in Working Capital | -854K | -960K | 4.32M | -828 | -33K | 1.53M | 3.67M | -1.88M | -1.55M | 1.84M | 815.52K | -1.61M | -656.8K | -132.17K | 1.23M | -1.4M | -596.48K |
Operating Cash Flow | -6.5M | -7.85M | -4.83M | -6.82M | -7.47M | -6.12M | -6.03M | -8.46M | -7.83M | -5.94M | -4.25M | -6.92M | -6.25M | -6.34M | -3.73M | -6.8M | -5.57M |
Capital Expenditures | n/a | -6K | -32K | -155 | -46K | -3K | n/a | n/a | -5K | 740.00 | -8.57K | -11.64K | -35.52K | -74.71K | -204.64K | -6.6K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | 6.77M | 6.79M | 6.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 6.77K | 6.79K | 6.67K | -20.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | -6K | -32K | -155K | -46K | -3K | 6.77M | 6.79M | 6.67M | -20.35M | -8.57K | -11.64K | -35.52K | -74.71K | -204.64K | -6.6K | n/a |
Debt Repayment | -103K | -100K | -80K | -65K | -103K | -104K | -102K | -100K | -101K | -101.59K | -96K | -93.67K | -89K | -80.01K | -75.27K | -98.56K | -111.67K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.23K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 65K | 2.04M | n/a | 375K | 63K | 343K | n/a | -242 | n/a | n/a | 12K | 37.5K | 4.83K | 6.77K | 420.3K |
Financial Cash Flow | 5.89M | 3.34M | -173K | 1.98M | 1.5M | 1.74M | 21.29M | 3.69M | 5.27M | 5.87M | 1.16M | 156.27K | 5.01M | -51.71K | -79.67K | 7.98M | 25.17M |
Net Cash Flow | -639K | -3.66M | -5.25M | -4.75K | -4.3M | -4.72M | 22.46M | 1.65M | 4.21M | -20.7M | -1.33M | -5.79M | -1.78M | -6.83M | -2.71M | 437.27K | 19.14M |
Free Cash Flow | -6.5M | -7.85M | -4.86M | -6.97K | -7.51M | -6.13M | -6.03M | -8.46M | -7.83M | -5.94M | -4.26M | -6.93M | -6.29M | -6.41M | -3.94M | -6.8M | -5.57M |